All News

The Mayo Clinic in Rochester, Minnesota, is at the top of the Best Hospitals ranking by U.S. News & World Report, and is included in the Top 5 lists for 3 selected specialties.

Globally, lung cancer mortality rates among women are projected to increase by 43% from 2015 to 2030.

Botox injections found to decrease urinary incontinence and improve quality of life for patients with multiple sclerosis.

Organ transplant recipients who received infected kidneys were cured of hepatitis C after taking antiviral therapy following the procedure.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Vizuri Health Sciences’ PainBloc24®, a new topical analgesic product containing capsaicin, has arrived on the retail market.

The designation was based on data from 7 clinical trials over the past decade, which assessed omalizumab’s efficacy and safety versus various food allergens, such as peanut, milk, and egg.

Officials with the FDA have approved migalastat (Galafold, Amicus Therapeutics), the first oral medication for the treatment of adults with Fabry disease.

Migalastat (Galafold, Amicus Therapeutics) is the first oral medication for the treatment of adults with Fabry disease, a rare genetic disorder.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

The FDA permitted marketing of the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

Midazolam Nasal Spray—from global biopharmaceutical company UCB, Brussels, Belgium (UCB)—has been previously granted Orphan Drug and Fast Track designations by the FDA

The annual cost of treating cancer is projected to rise to $173 billion by 2020, a 39% increase since 2010.

The guidelines fill an unmet clinical need for a standard care consensus on gestational trophoblastic neoplasia, a group of rare cancers that affect pregnant women.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Pharmacy benefit manager says it retained approximately $300 million in drug rebates, well under the $2 billion amount that some projected.

The FDA has approved a combined hormonal contraceptive for women that is the first vaginal ring contraceptive that can be used for an entire year.

Officials with the FDA have approved the first targeted treatment for adult patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis, a rare and often fatal disease.

Patisiran (Onpattro, Alnylam Pharmaceuticals) is indicated for the treatment of adult patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR), a rare genetic disease.

The FDA has permitted marketing of Natural Cycles, the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

The results of a recent UK study reveal that psychological distress, whether considered low or moderate, can increase a patient’s risk for chronic obstructive pulmonary disease (COPD), arthritis, and cardiovascular disease (CVD).

As health care providers work to combat the growing abuse epidemic, the results of a new study suggest that interventions using behavioral insights can change the course of care.

In response to the CMS’ step therapy approach to lowering drug costs, many advocacy groups expressed concern that the move will harm patient access to treatments for chronic conditions.

Higher-than-recommended physical activity levels can help older adults avoid chronic diseases, disability, and cognitive decline for longer.

Top news of the day from across the health care landscape.

This action, aimed at saving patients money, is part of the Trump administration’s larger agenda to create competition among medications that treat the same conditions.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.